Accessibility/Mobile Features
Skip Navigation
Skip to Content
Editorial News
Business
Classified Sites

The Canadian Press - ONLINE EDITION

Pfizer underscores its commitments to Britain in memo to parliamentary committees

FILE- In this Friday, May 2, 2014 file photo, an exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London. Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of the Anglo-British firm AstraZeneca, insisting that its promises will be legally binding. In a memo Monday, May 12, 2104 to two parliamentary committees studying its proposed takeover, the U.S. drugmaker laid outs its vision ahead of testimony before the science and business committees. Crucially, the company sought to ease worries that British jobs will be lost and that the nation's science base will be undermined by the potential merger. (AP Photo/Matt Dunham, File)

Enlarge Image

FILE- In this Friday, May 2, 2014 file photo, an exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London. Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of the Anglo-British firm AstraZeneca, insisting that its promises will be legally binding. In a memo Monday, May 12, 2104 to two parliamentary committees studying its proposed takeover, the U.S. drugmaker laid outs its vision ahead of testimony before the science and business committees. Crucially, the company sought to ease worries that British jobs will be lost and that the nation's science base will be undermined by the potential merger. (AP Photo/Matt Dunham, File)

LONDON - Pfizer Inc. has sought to allay concerns over its proposed $106 billion takeover offer of Anglo-Swedish pharmaceuticals firm AstraZeneca, insisting that its promises will be legally binding.

In a memo Monday to two U.K. parliamentary committees studying its proposed overture, the U.S. drugmaker laid out its vision ahead of its testimony before the science and business committees. Crucially, it sought to ease worries that British jobs will be lost and that the nation's science base eroded by the potential merger.

It repeated promises to complete AstraZeneca's research and development hub in Cambridge and to establish the new company's tax residence in England.

"Delivering on these commitments will make us a stronger company that delivers benefits to patients, value to shareholders, and creates and protects high value jobs," the memo said.

The maker of Viagra has already written to U.K. Prime Minister David Cameron to offer commitments, but the memo bolstered the message, saying the promises were "binding as a matter of English law."

The cash and stock deal has become politically fraught, with much of the debate centring on whether Pfizer can be trusted to honour promises in what would be the biggest foreign takeover of a British business. Cameron has been accused by the opposition Labour Party of being a cheerleader for the deal.

The British leader was forced Sunday in a BBC interview to reject the notion that he was favouring Pfizer. But he also said Britain should not "put up the drawbridge" to outside investment.

Pfizer has made three approaches to AstraZeneca since January — all of which have been rejected. AstraZeneca said Pfizer's latest offer undervalues the company and that a takeover would disrupt its work on a potentially lucrative pipeline of new drugs.

The potential deal comes amid a spate of mergers among pharmaceutical companies, who are seeking to find new ways to grow as generic drugmakers move in to make cheaper versions of products with expiring patents.

  • Rate this Rate This Star Icon
  • This article has not yet been rated.
  • We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high. If you thought it was well written, do the same. If it doesn’t meet your standards, mark it accordingly.

    You can also register and/or login to the site and join the conversation by leaving a comment.

    Rate it yourself by rolling over the stars and clicking when you reach your desired rating. We want you to tell us what you think of our articles. If the story moves you, compels you to act or tells you something you didn’t know, mark it high.

Sort by: Newest to Oldest | Oldest to Newest | Most Popular 0 Commentscomment icon

You can comment on most stories on brandonsun.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.

There are no comments at the moment. Be the first to post a comment below.

Post Your Commentcomment icon

Comment
  • You have characters left

The Brandon Sun does not necessarily endorse any of the views posted. Comments are moderated before publication. By submitting your comment, you agree to our Terms and Conditions. New to commenting? Check out our Frequently Asked Questions.

letters

Make text: Larger | Smaller

Brandon Sun Business Directory
Sudden Surge: Flood of 2014
Opportunity Magazine — The Bakken
Why Not Minot?
Welcome to Winnipeg

Social Media

Canadian Mortgage Rates